Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease

Guang Shi1, Jeffrey R Lee, David A Grimes

  • 1Department of Biochemistry, University of Toronto, 1 King's College Circle, Toronto, ON, Canada M5S 1A8.

Insights

Mitochondrial protease PARL regulates PINK1 processing, crucial for clearing damaged mitochondria via mitophagy. PARL mutations impair this process, potentially contributing to Parkinson's disease pathogenesis.

Area of Science:

  • Molecular genetics
  • Cell biology
  • Neurodegenerative disease research

Background:

  • Mitochondrial dysfunction is linked to Parkinson's disease (PD) pathogenesis.
  • Mutations in PTEN-induced kinase-1 (PINK1) and PARKIN cause recessive PD.
  • PINK1 recruits PARKIN to initiate mitophagy, removing damaged mitochondria.

Purpose of the Study:

  • Investigate the role of presenilin-associated rhomboid-like (PARL) protease in PINK1 processing.
  • Determine if PARL affects PINK1 localization, stability, and interaction with PARKIN.
  • Explore the potential role of PARL mutations in PD.

Main Methods:

  • Studied the effect of PARL on PINK1 proteolytic processing.
  • Assessed PINK1 localization and stability in PARL-deficient cells.
  • Analyzed PARKIN recruitment to mitochondria.
  • Sequenced the PARL gene in Parkinson's disease patients.

Main Results:

  • PARL affects PINK1 proteolytic processing; its catalytic activity is required for normal PINK1 localization and stability.
  • PARL deficiency impairs PARKIN recruitment to mitochondria.
  • A novel PARL missense mutation was identified in PD patients.
  • The identified PARL mutant failed to rescue PARKIN recruitment.

Conclusions:

  • PINK1 processing and localization, regulated by PARL, are critical for PARKIN interaction and mitophagy.
  • Impaired mitophagy due to PARL dysfunction may underlie Parkinson's disease in patients with PARL mutations.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.